us-ftc-hsr-informal-interpretations-4b63f0689583aca09a0a12fe70e4877d•0712011 Informal Interpretation
0712011 Informal Interpretation
us-ftc-hsr-informal-interpretations-4b63f0689583aca09a0a12fe70e4877d0712011 Informal InterpretationGuidance
Question
From:(redacted)
Sent:Tuesday, December 18, 2007 8:45 PM
To:Verne, B. Michael
Subject:License question
Hi,Mike -
Wouldyou mind giving your thoughts on the following:
CompanyA will license to Company B certain technology and intellectual property rightswith respect to several pharmaceutical products (the "LicensedProducts") for a three year period in the U.S. The license purports to bean "exclusive" license; however, Company A retains the right tomanufacture the Licensed Products for sale to Company B or resale outside ofthe U.S. At the end of three years, Company B will have the option to purchaseCompany A's title and interest in and to the NDAs, ANDAs, trademarks and otherassets related to the Licensed Products, including obtaining manufacturing rightsto such products. Do you agree that the initial license is non-exclusive forHSR purposes and will not be deemed to be the transfer of an asset due to thefact that Company A retains manufacturing rights? Do you further agree that anHSR filing may be triggered in three years time if Company B decides toexercise the option to purchase the Licensed Products (such HSR filing to bemade prior to Company B obtaining beneficial ownership of such products,assuming the jurisdictional thresholds of the HSR Act are met)?
Vous vous demandez comment ce texte s’applique à votre situation ?
Consultation gratuite, sans engagement
Décrivez votre situation. Notre équipe vous recontactera par e-mail pour votre consultation.
Poursuivez vos recherches dans ChatGPT ou Claude
Connectez Omnilex pour rechercher dans le corpus juridique depuis votre assistant IA.